Sign in to view content

Multicenter Randomized Sham-Controlled Double-Masked Phase 2b Clinical Trial of Multi-Characteristic Opsin in Patients With Advanced Retinitis Pigmentosa

Peter K. Kaiser, MD FASRS

Video
Published 2022

Related

Microscope-Integrated Optical Coherence Tomography Can Measure the Volume of Subretinal Blebs Created by a Suprachoroidal Approach
Ananth Sastry, MD
Annual Meeting Talks
2020
Wet AMD 2 Symposium
Annual Meeting Talks
2020
Elamipretide, a Mitochondria-Targeted Drug for the Treatment of Vision Loss
Scott W. Cousins, MD
Updates from the Field
2019

Category: Hereditary Retinal Disease & Genetics

See more